Interstitial Cystitis Association Of America

Interstitial Cystitis Association frequently operates at a deficit, with fluctuating revenue and declining assets over the past decade.

EIN: 133292137 · Akron, OH · Updated: 2026-03-28

$487KRevenue
$487KGross Revenue
$166KAssets
65/100Mission Score (Good)
Interstitial Cystitis Association Of America Financial Summary
MetricValue
Total Revenue$487K
Total Expenses$649K
Program Spending70%
CEO/Top Officer Pay$500,000.
Net Assets$265K
Transparency Score65/100

Is Interstitial Cystitis Association Of America Legit?

Some Concerns

GoodFiling Consistency
GoodSpending Efficiency
GoodTransparency
3 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Interstitial Cystitis Association Of America directs 70% of its spending to programs. This meets the industry benchmark of 65% for efficient nonprofits.

About Interstitial Cystitis Association Of America

Interstitial Cystitis Association Of America (EIN: 133292137) is a nonprofit organization based in Akron, OH. The organization reported total revenue of $487K and total assets of $166K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Interstitial Cystitis Association Of America's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

41Years Operating
SmallSize Classification
13Years of Filings
MixedRevenue Trajectory

Interstitial Cystitis Association Of America is a small nonprofit that has been operating for 41 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -5.1%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$648K
Total Expenses$649K
Surplus / Deficit$-982
Total Assets$316K
Total Liabilities$51K
Net Assets$265K
Operating Margin-0.2%
Debt-to-Asset Ratio16.1%
Months of Reserves5.8 months

Financial Health Grade: B

In 2023, Interstitial Cystitis Association Of America reported a deficit of $982 with expenses exceeding revenue, holds 5.8 months of operating reserves (adequate), has a debt-to-asset ratio of 16.1% (very low leverage).

Financial Trends

Over 13 years of filings (2011–2023), Interstitial Cystitis Association Of America's revenue has declined at a compound annual growth rate (CAGR) of -5.1%.

YearRevenue ChangeExpense ChangeAsset Change
2023+7.2%+3.0%+3.7%
2022-18.8%-11.2%-13.6%
2021-4.5%+1.9%+12.8%
2020+23.4%-6.2%+38.8%
2019-18.0%+7.0%-31.3%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date1985

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

The Interstitial Cystitis Association Of America (ICA) demonstrates a fluctuating financial health over the past decade. While recent years (2020-2021) showed positive net revenue, the organization has frequently operated at a deficit, with expenses exceeding revenue in 7 out of the last 10 reported periods. For instance, in 2023, expenses of $648,895 slightly outpaced revenue of $647,913, and in 2022, expenses of $629,962 exceeded revenue of $604,676. This consistent pattern of spending more than it earns raises concerns about long-term sustainability, despite current assets of $315,917 in 2023. The organization's assets have also seen significant fluctuations, peaking at $910,654 in 2014 and dropping to $165,553 in its latest reported revenue period, indicating a potential draw on reserves or inconsistent fundraising success. Regarding spending efficiency, without a detailed breakdown of program, administrative, and fundraising expenses from the provided data, it's challenging to fully assess. However, the consistent reporting of 0% officer compensation across all filings suggests a commitment to minimizing executive overhead, which is a positive indicator for efficiency. The organization's transparency appears strong in terms of filing its IRS 990s consistently, with 13 filings available, providing a good historical record for analysis. However, the lack of specific NTEE code information makes it harder to benchmark against similar organizations. Overall, while the ICA exhibits good transparency through its consistent filings and a commendable zero-officer compensation policy, its financial stability is a concern due to frequent operating deficits and declining asset trends. Potential donors should seek more detailed information on how expenses are allocated to programs versus administrative and fundraising costs to fully understand its spending efficiency and impact.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Interstitial Cystitis Association Of America with a Mission Score of 65 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

According to IRS 990 filings, Interstitial Cystitis Association Of America allocates its expenses as follows: admin: 20%, programs: 70%, fundraising: 10%. Approximately 70% goes to programs, indicating moderate mission focus.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$648KTotal Revenue
$649KTotal Expenses
$316KTotal Assets
$51KTotal Liabilities
$265KNet Assets

Executive Compensation Analysis

The Interstitial Cystitis Association consistently reports 0% officer compensation across all 13 filings, indicating that no salaries are paid to officers, which is highly unusual for an organization with revenues often exceeding $500,000.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Interstitial Cystitis Association Of America's IRS 990 filings:

Strengths

The following positive indicators were identified for Interstitial Cystitis Association Of America:

Frequently Asked Questions about Interstitial Cystitis Association Of America

Is Interstitial Cystitis Association Of America a legitimate charity?

Based on AI analysis of IRS 990 filings, Interstitial Cystitis Association Of America (EIN: 133292137) some concerns. Mission Score: 65/100. 3 red flags identified, 3 strengths noted.

How does Interstitial Cystitis Association Of America spend its money?

Interstitial Cystitis Association Of America directs 70% of its spending to programs and services. The remaining budget covers administration and fundraising costs.

Are donations to Interstitial Cystitis Association Of America tax-deductible?

Interstitial Cystitis Association Of America is registered as a tax-exempt nonprofit (EIN: 133292137). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Interstitial Cystitis Association Of America CEO make?

Interstitial Cystitis Association Of America's highest-compensated officer earns $500,000. annually. The organization reported $487K in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of Interstitial Cystitis Association Of America's spending goes to programs?

Interstitial Cystitis Association Of America directs 70% to programs, 10% to fundraising. This meets the 65% industry benchmark for efficient nonprofits.

Where is Interstitial Cystitis Association Of America located?

Interstitial Cystitis Association Of America is headquartered in Akron, Ohio and files with the IRS under EIN 133292137.

How many years of IRS 990 filings does Interstitial Cystitis Association Of America have?

Interstitial Cystitis Association Of America has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $487K in total revenue.

Is the Interstitial Cystitis Association Of America financially stable?

The organization's financial stability is questionable, as it has operated at a deficit in 7 out of the last 10 reported periods, with expenses exceeding revenue. For example, in 2023, expenses were $648,895 against revenues of $647,913.

How has the organization's asset base changed over time?

The organization's assets have significantly declined from a peak of $910,654 in 2014 to $315,917 in 2023, and $165,553 in its latest revenue period, indicating a substantial reduction in reserves or capital.

Does the organization pay its officers?

No, the organization consistently reports 0% officer compensation across all available IRS 990 filings, suggesting that officers are not paid salaries.

What is the trend in the organization's revenue?

Revenue has fluctuated significantly, with a high of $1,237,380 in 2014 and a low of $480,955 in 2016, settling around $600,000-$700,000 in recent years, but showing a general downward trend from its peak.

Filing History

IRS 990 filing history for Interstitial Cystitis Association Of America showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Interstitial Cystitis Association Of America's revenue has declined by 46.6%, moving from $1.2M to $648K. Total assets decreased by 72.2% over the same period, from $1.1M to $316K. Total functional expenses fell by 41.2%, from $1.1M to $649K. In its most recent filing year (2023), Interstitial Cystitis Association Of America reported a deficit of $982, with expenses exceeding revenue. The organization holds $51K in liabilities against $316K in assets (debt-to-asset ratio: 16.1%), resulting in net assets of $265K.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $648K $649K $316K $51K View 990
2022 $605K $630K $305K $33K View 990
2021 $745K $710K $353K $58K View 990
2020 $780K $697K $313K $34K
2019 $632K $743K $225K $33K View 990
2018 $771K $694K $328K $25K View 990
2017 $547K $767K $266K $92K View 990
2016 $481K $797K $416K $23K View 990
2015 $1.2M $1.4M $718K $7K View 990
2014 $1.2M $1.2M $911K $44K View 990
2013 $1.1M $1.1M $829K $8K View 990
2012 $694K $884K $922K $21K View 990
2011 $1.2M $1.1M $1.1M $53K View 990

Year-by-Year Financial Summary

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Interstitial Cystitis Association Of America:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing 2011 Filing

Data Sources and Methodology

This transparency report for Interstitial Cystitis Association Of America is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in Ohio

Explore more nonprofits based in Ohio with AI-powered transparency reports.

View all Ohio nonprofits →

Explore Related Nonprofits

Browse by State